Teledermatology for diagnosing skin cancer in adults.
Open accessThe DOI matches its Crossref record; 269 of the 289 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Early accurate detection of all skin cancer types is essential to guide appropriate management and to improve morbidity and survival. Melanoma and squamous cell carcinoma (SCC) are high-risk skin cancers which have the potential to metastasise and ultimately lead to death, whereas basal cell carcinoma (BCC) is usually localised with potential to infiltrate and damage surrounding tissue. Anxiety around missing early curable cases needs to be balanced against inappropriate referral and unnecessary excision of benign lesions. Teledermatology provides a way for generalist clinicians to access the opinion of a specialist dermatologist for skin lesions that they consider to be suspicious without referring the patients through the normal referral pathway. Teledermatology consultations can be 'store-and-forward' with electronic digital images of a lesion sent to a dermatologist for review at a later time, or can be live and interactive consultations using videoconferencing to connect the patient, referrer and dermatologist in real time. OBJECTIVES: To determine the diagnostic accuracy of teledermatology for the detection of any skin cancer (melanoma, BCC or cutaneous squamous cell carcinoma (cSCC)) in adults, and to compare its accuracy with that of in-person diagnosis. SEARCH METHODS: We undertook a comprehensive search of the following databases from inception up to August 2016: Cochrane Central Register of Controlled Trials, MEDLINE, Embase, CINAHL, CPCI, Zetoc, Science Citation Index, US National Institutes of Health Ongoing Trials Register, NIHR Clinical Research Network Portfolio Database and the World Health Organization International Clinical Trials Registry Platform. We studied reference lists and published systematic review articles. SELECTION CRITERIA: Studies evaluating skin cancer diagnosis for teledermatology alone, or in comparison with face-to-face diagnosis by a specialist clinician, compared with a reference standard of histological confirmation or clinical follow-up and expert opinion. We also included studies evaluating the referral accuracy of teledermatology compared with a reference standard of face-to-face diagnosis by a specialist clinician. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted all data using a standardised data extraction and quality assessment form (based on QUADAS-2). We contacted authors of included studies where there were information related to the target condition of any skin cancer missing. Data permitting, we estimated summary sensitivities and specificities using the bivariate hierarchical model. Due to the scarcity of data, we undertook no covariate investigations for this review. For illustrative purposes, we plotted estimates of sensitivity and specificity on coupled forest plots for diagnostic threshold and target condition under consideration. MAIN RESULTS: The review included 22 studies reporting diagnostic accuracy data for 4057 lesions and 879 malignant cases (16 studies) and referral accuracy data for reported data for 1449 lesions and 270 'positive' cases as determined by the reference standard face-to-face decision (six studies). Methodological quality was variable with poor reporting hindering assessment. The overall risk of bias was high or unclear for participant selection, reference standard, and participant flow and timing in at least half of all studies; the majority were at low risk of bias for the index test. The applicability of study findings were of high or unclear concern for most studies in all domains assessed due to the recruitment of participants from secondary care settings or specialist clinics rather than from primary or community-based settings in which teledermatology is more likely to be used and due to the acquisition of lesion images by dermatologists or in specialist imaging units rather than by primary care clinicians.Seven studies provided data for the primary target condition of any skin cancer (1588 lesions and 638 malignancies). For the correct diagnosis of lesions as malignant using photographic images, summary sensitivity was 94.9% (95% confidence interval (CI) 90.1% to 97.4%) and summary specificity was 84.3% (95% CI 48.5% to 96.8%) (from four studies). Individual study estimates using dermoscopic images or a combination of photographic and dermoscopic images generally suggested similarly high sensitivities with highly variable specificities. Limited comparative data suggested similar diagnostic accuracy between teledermatology assessment and in-person diagnosis by a dermatologist; however, data were too scarce to draw firm conclusions. For the detection of invasive melanoma or atypical intraepidermal melanocytic variants both sensitivities and specificities were more variable. Sensitivities ranged from 59% (95% CI 42% to 74%) to 100% (95% CI 48% to 100%) and specificities from 30% (95% CI 22% to 40%) to 100% (95% CI 93% to 100%), with reported diagnostic thresholds including the correct di
Overview
CoChat Summary
TL;DR
This Cochrane diagnostic test accuracy review found that teledermatology can correctly identify most malignant skin lesions, with summary sensitivity of 94.9% for photographic images in detecting any skin cancer, but specificity was highly variable. Evidence was limited, heterogeneous, and mostly from specialist settings, so firm conclusions about triage and comparison with in-person diagnosis are not possible.
Key findings
- The review included 22 studies: 16 diagnostic accuracy studies reporting 4057 lesions and 879 malignant cases, and 6 referral accuracy studies reporting 1449 lesions and 270 “positive” cases.
- Seven studies provided data for the primary target condition of any skin cancer (1588 lesions and 638 malignancies). For photographic images, summary sensitivity was 94.9% (95% CI 90.1% to 97.4%) and summary specificity was 84.3% (95% CI 48.5% to 96.8%) from four studies; dermoscopic or combined photographic/dermoscopic images generally showed similarly high sensitivities with highly variable specificities.
- For invasive melanoma or atypical intraepidermal melanocytic variants, sensitivities ranged from 59% (95% CI 42% to 74%) to 100% (95% CI 48% to 100%) and specificities from 30% (95% CI 22% to 40%) to 100% (95% CI 93% to 100%).
- Referral accuracy showed sensitivities over 90% for lesions requiring positive action, but for less-concern lesions teledermatology specificities ranged from 57% (95% CI 39% to 73%) to 100% (95% CI 86% to 100%), suggesting remote assessment is more likely to recommend excision, referral, or follow-up than in-person decisions.
Methods
- Systematic review of diagnostic test accuracy with a comprehensive search from inception to August 2016 across Cochrane Central Register of Controlled Trials, MEDLINE, Embase, CINAHL, CPCI, Zetoc, Science Citation Index, trials registries, and reference lists.
- Included studies evaluated teledermatology alone or compared with face-to-face diagnosis by a specialist clinician, using histological confirmation or clinical follow-up and expert opinion as reference standards; referral accuracy studies compared teledermatology with face-to-face specialist diagnosis.
- Two review authors independently extracted data and assessed quality using QUADAS-2; where data permitted, summary sensitivities and specificities were estimated using a bivariate hierarchical model, with no covariate investigations due to data scarcity, and coupled forest plots used for illustration.
Limitations
- The paper states studies were generally small and heterogeneous, and methodological quality was difficult to judge due to poor reporting; risk of bias was high or unclear for participant selection, reference standard, and participant flow/timing in at least half of studies, while most were at low risk for the index test.
- The paper states applicability was of high or unclear concern for most studies across all domains because participants were recruited from secondary care or specialist clinics rather than primary or community settings, and lesion images were acquired by dermatologists or in specialist imaging units rather than by primary care clinicians.
- The paper states data were too scarce to draw firm conclusions about comparative accuracy between teledermatology and in-person diagnosis; evident from the text, the plain language summary also notes average age of 52 years, some studies including people under 16, and skin cancer prevalence ranging from 2% to 88% (average 30%), much higher than UK primary care, limiting generalizability.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 0 Not checked · 42 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Limited comparative data suggested similar diagnostic accuracy between teledermatology assessment and in-person diagnosis by a dermatologist; however, data were too scarce to draw firm conclusions.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For the correct diagnosis of lesions as malignant using photographic images, summary sensitivity was 94.9% (95% confidence interval (CI) 90.1% to 97.4%) and summary specificity was 84.3% (95% CI 48.5% to 96.8%) (from four studies).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sensitivities ranged from 59% (95% CI 42% to 74%) to 100% (95% CI 48% to 100%) and specificities from 30% (95% CI 22% to 40%) to 100% (95% CI 93% to 100%), with reported diagnostic thresholds including the correct diagnosis of melanoma, classification of lesions as 'atypical' or 'typical, and the decision to refer or to excise a lesion.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For the detection of invasive melanoma or atypical intraepidermal melanocytic variants both sensitivities and specificities were more variable.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A single reliable estimate of the accuracy of teledermatology could not be made.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
22 more claims
Create a free account to see all 42 claims and every source verdict.
- Probably not a substantial claim. 6
- It may state two separate claims as one. 9
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“and five studies comparing teledermatology decisions to the decisions that would be made with the patient present (referral accuracy) for 1449 lesions and 270 'positive' cases.”
“Referral accuracy 6 1449 270”
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Self-citationSiegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · BMJ · doi:10.1136/bmj.h5527 · Cited by 3,660
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Deeks, J. J., Macaskill, P., & Irwig, L. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.016 · Cited by 2,910
Self-citationGershenwald, J. E., Scolyer, R. A., Hess, K. R., Sondak, V. K., Long, G. V., Ross, M. I., Lazar, A. J., Faries, M. B., Kirkwood, J. M., McArthur, G. A., et al. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21409 · Cited by 2,283
A systematic review of worldwide incidence of nonmelanoma skin cancer
Lomas, A., Leonardi‐Bee, J., & Bath‐Hextall, F. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10830.x · Cited by 1,937
Interval estimation for the difference between independent proportions: comparison of eleven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<873::aid-sim779>3.0.co;2-i · Cited by 1,851
Rowe, D. E., Carroll, R. J., & Day, C. L. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70144-5 · Cited by 1,503
Research works printed but not linked: 7
- Bataille, 2011, A teledermatology pilot study in Hertfordshire: triage of 2-week-wait referrals, British Journal of Dermatology, 165, 137
- D'Elia, 2007, Agreement between dermatological diagnoses made by direct observation and digital images, Anais Brasileiros de Dermatologia, 82, 521
- Ndegwa, 2010, Teledermatology services: rapid review of diagnostic, clinical management, and economic outcomes
- Pak, 2003, Teledermatology: an intraobserver diagnostic correlation study, part I, Cutis, 71, 399
- Australian Cancer Database, 2017, Melanoma of the skin for Australia (ICD10 C43)
- Carli, 1994, Epiluminescence microscopy reduces the risk of removing clinically atypical, but histologically common, melanocytic lesions, Giornale Italiano di Dermatologia e Venereologia, 129, 599
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
Cited by
Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults
Dinnes, J., Deeks, J. J., Chuchu, N., Ferrante di Ruffano, L., Matin, R. N., Thomson, D. R., Wong, K. Y., Aldridge, R. B., Abbott, R., Fawzy, M., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011902.pub2 · Cited by 232
Self-citationPhillips, M., Marsden, H., Jaffe, W., Matin, R. N., Wali, G. N., Greenhalgh, J., McGrath, E., James, R., Ladoyanni, E., Bewley, A., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13436 · Cited by 223
Self-citationBhaskar, S., Bradley, S., Chattu, V. K., Adisesh, A., Nurtazina, A., Kyrykbayeva, S., Sakhamuri, S., Moguilner, S., Pandya, S., Schroeder, S., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00410 · Cited by 176
“Teledermatology is another promising perspective in the diagnosis and monitoring of skin lesions, including cancer (54).”
BackgroundSmartphone applications for triaging adults with skin lesions that are suspicious for melanoma
Chuchu, N., Takwoingi, Y., Dinnes, J., Matin, R. N., Bassett, O., Moreau, J. F., Bayliss, S. E., Davenport, C., Godfrey, K., O'Connell, S., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013192 · Cited by 144
Self-citationFerrante di Ruffano, L., Takwoingi, Y., Dinnes, J., Chuchu, N., Bayliss, S. E., Davenport, C., Matin, R. N., Godfrey, K., O'Sullivan, C., Gulati, A., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013186 · Cited by 142
Self-citation
Metadata
- Authors
- Chuchu, N., Dinnes, J., Takwoingi, Y., Matin, R. N., Bayliss, S. E., Davenport, C., Moreau, J. F., Bassett, O., Godfrey, K., O'Sullivan, C., Walter, F. M., Motley, R., Deeks, J. J., Williams, H. C., & Cochrane Skin Cancer Diagnostic Test Accuracy Group
- Affiliations
- University of Birmingham (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Churchill Hospital (GB)
- University of Pittsburgh Medical Center (US)
- Addenbrooke's Hospital (GB)
- University of Nottingham (GB)
- University of Cambridge (GB)
- University Hospital of Wales (GB)
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-12-04
- Volume
- 2018
- Issue
- 12
- Pages
- CD013193-CD013193
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6517019
- OpenAlex
- W2904735719
- Semantic Scholar
- dd9cbaf26b19674f5fe73996be533e35ecdc0a21
- Cited by
- 175
- References
- 289
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 30 · 2023: 25 · 2022: 22 · 2021: 32 · 2020: 20 · 2019: 9 · 2018: 8
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- National Institute for Health and Care Research (13/89/15, NIHR-CS-012-030)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Dermatology › Nonmelanoma Skin Cancer Studies
- Keywords
- teledermatology, skin cancer diagnosis, melanoma, basal cell carcinoma, cutaneous squamous cell carcinoma, store-and-forward telemedicine, videoconferencing, diagnostic accuracy, sensitivity and specificity, early detection of skin cancer, adults, histopathological confirmation
- MeSH terms
- Data Accuracy, Cutaneous Malignant Melanoma, Adult, Basal Cell Carcinoma, Carcinoma, Squamous Cell, Dermatology, Diagnostic Errors, Humans, Melanoma, Photography, Physical Examination, Sensitivity and Specificity, Skin Neoplasms, Telemedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Teledermatology for diagnosing skin cancer in adults. https://app.cochat.ai/papers/10.1002/14651858.cd013193
- The paper
- Chuchu, N., Dinnes, J., Takwoingi, Y., Matin, R. N., Bayliss, S. E., Davenport, C., Moreau, J. F., Bassett, O., Godfrey, K., O'Sullivan, C., Walter, F. M., Motley, R., Deeks, J. J., Williams, H. C., & Cochrane Skin Cancer Diagnostic Test Accuracy Group. (2018). Teledermatology for diagnosing skin cancer in adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd013193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.